Neurocrine Biosciences (NBIX) Share-based Compensation (2009 - 2026)
Neurocrine Biosciences (NBIX) reported Share-based Compensation of $54.3 million for Q3 2026, up 1.1% from $53.7 million a year earlier but down 16.5% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Share-based Compensation (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Neurocrine Biosciences' Share-based Compensation came in at $235.1 million, up 4.2% year-over-year; for FY2025, it was $217.9 million, up 11.5% from FY2024.
- Share-based Compensation has increased for 14 consecutive years, with a five-year compound annual growth rate of 16.9% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $195.5 million in FY2024 (+0.6%), $194.3 million in FY2023 (+12.2%), $173.1 million in FY2022 (+29.0%) and $134.2 million in FY2021 (+34.2%).
- Five-year quarterly Share-based Compensation spans a low of $35.6 million in Q4 2021 and a high of $68.5 million in Q2 2023.
- Year over year, Share-based Compensation has now increased in each of the last three quarters, with growth averaging 20.7% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q4 2024 (growth of 74.3%); the low point was Q2 2024 (a decline of 37.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $65 million (Q2 2026), $57.2 million (Q1 2026) and $58.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 54.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 54.30 Mn |
| Jun 30, 2026 | 65.00 Mn |
| Mar 31, 2026 | 57.20 Mn |
| Dec 31, 2025 | 58.60 Mn |
| Sep 30, 2025 | 53.70 Mn |
| Jun 30, 2025 | 52.80 Mn |
| Mar 31, 2025 | 52.80 Mn |
| Dec 31, 2024 | 66.40 Mn |
| Sep 30, 2024 | 41.50 Mn |
| Jun 30, 2024 | 43.10 Mn |
| Mar 31, 2024 | 44.50 Mn |
| Dec 31, 2023 | 38.10 Mn |
| Sep 30, 2023 | 47.80 Mn |
| Jun 30, 2023 | 68.50 Mn |
| Mar 31, 2023 | 39.90 Mn |
| Dec 31, 2022 | 43.50 Mn |
| Sep 30, 2022 | 43.10 Mn |
| Jun 30, 2022 | 49.50 Mn |
| Mar 31, 2022 | 37.00 Mn |
| Dec 31, 2021 | 35.60 Mn |
API Access
Neurocrine Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();